Therapeutic anticoagulation using heparin in early phase severe coronavirus disease 2019: A retrospective study

BACKGROUND: Although several reports recommend the use of systemic anticoagulation therapy in patients with severe coronavirus disease 2019 (COVID-19) pneumonia, appropriate target population and timing of administration are unknown. We assessed association between therapeutic anticoagulation admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Wataru, Endo, Akira, Otomo, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135498/
https://www.ncbi.nlm.nih.gov/pubmed/35640454
http://dx.doi.org/10.1016/j.ajem.2022.05.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135498/
https://www.ncbi.nlm.nih.gov/pubmed/35640454
http://dx.doi.org/10.1016/j.ajem.2022.05.031

Ejemplares similares